{"id":33920,"date":"1998-01-01T00:00:00","date_gmt":"1998-01-01T00:00:00","guid":{"rendered":"https:\/\/www.deberes.net\/tesis\/sin-categoria\/estudio-aleatorizado-con-interferon-y-ribavirina-frente-a-interferon-en-pacientes-con-hepatitis-cronica-c-resistentes-al-interferon\/"},"modified":"1998-01-01T00:00:00","modified_gmt":"1998-01-01T00:00:00","slug":"estudio-aleatorizado-con-interferon-y-ribavirina-frente-a-interferon-en-pacientes-con-hepatitis-cronica-c-resistentes-al-interferon","status":"publish","type":"post","link":"https:\/\/www.deberes.net\/tesis\/ciencias-medicas\/estudio-aleatorizado-con-interferon-y-ribavirina-frente-a-interferon-en-pacientes-con-hepatitis-cronica-c-resistentes-al-interferon\/","title":{"rendered":"Estudio aleatorizado con interferon y ribavirina frente a interferon en pacientes con hepatitis cronica c resistentes al interferon."},"content":{"rendered":"<h2>Tesis doctoral de <strong> Isabel Lavin Castejon <\/strong><\/h2>\n<p>El tratamiento m\u00e1s utilizado en la hepatitis cr\u00f3nica c (hcc) ha sido el interfer\u00f3n (ifn), sin embargo, solamente un 25% de los pacientes responden con normalizaci\u00f3n de transaminasas y negativizaci\u00f3n de viremia. Esto ha hecho necesario la b\u00fasqueda de nuevas alternativas como la ribavirina. Por ello nos planteamos la realizaci\u00f3n de un estudio con 62 pacientes aleatorizados en dos grupos:  grupo a, con 31 enfermos tratados con ifn a 3 mu\/3 veces por semana y grupo b con otros 31 pacientes a los que se adminstraba la misma dosis de ifn y ribavirina a 600 mg\/ d\u00eda durante 6 meses. Se valor\u00f3 la respuesta bioqu\u00edmica y virol\u00f3gica, observando que s\u00f3lo 4 pacientes, dos de cada grupo, presentaba respuesta completa mantenida con normalizaci\u00f3n de transaminasas y 11 enfermos, 4 del grupo a y 7 del grupo b, hab\u00edan negativizado la viremia al finalizar el tratamiento. Posteriormente en el seguimiento a largo plazo, s\u00f3lo 3 pacientes (1 del grupo a y 2 del grupo b) permanec\u00edan con arn-vhc negativo. En conclusi\u00f3n, la asociaci\u00f3n de ifn y ribavirina a 600 mg\/d\u00eda no es efectiva en el tratamiento de la hcc resistente al ifn.<\/p>\n<p>&nbsp;<\/p>\n<h3>Datos acad\u00e9micos de la tesis doctoral \u00ab<strong>Estudio aleatorizado con interferon y ribavirina frente a interferon en pacientes con hepatitis cronica c resistentes al interferon.<\/strong>\u00ab<\/h3>\n<ul>\n<li><strong>T\u00edtulo de la tesis:<\/strong>\u00a0 Estudio aleatorizado con interferon y ribavirina frente a interferon en pacientes con hepatitis cronica c resistentes al interferon. <\/li>\n<li><strong>Autor:<\/strong>\u00a0 Isabel Lavin Castejon <\/li>\n<li><strong>Universidad:<\/strong>\u00a0 Granada<\/li>\n<li><strong>Fecha de lectura de la tesis:<\/strong>\u00a0 01\/01\/1998<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>Direcci\u00f3n y tribunal<\/h3>\n<ul>\n<li><strong>Director de la tesis<\/strong>\n<ul>\n<li>Javier Salmeron Escobar<\/li>\n<\/ul>\n<\/li>\n<li><strong>Tribunal<\/strong>\n<ul>\n<li>Presidente del tribunal: Blas Gil Extremera <\/li>\n<li>Manuel De La Mata Garcia (vocal)<\/li>\n<li>Gonzalo Mi\u00f1o Fugarolas (vocal)<\/li>\n<li> Martin Ruiz Jos\u00e9 Luis (vocal)<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tesis doctoral de Isabel Lavin Castejon El tratamiento m\u00e1s utilizado en la hepatitis cr\u00f3nica c (hcc) ha sido el interfer\u00f3n [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[9,1085,2445,957,139],"tags":[3355,2063,92078,2071,2045,39183],"class_list":["post-33920","post","type-post","status-publish","format-standard","hentry","category-ciencias-medicas","category-enfermedades-infecciosas","category-evaluacion-de-farmacos","category-farmacologia","category-medicina-interna","tag-blas-gil-extremera","tag-gonzalo-mino-fugarolas","tag-isabel-lavin-castejon","tag-javier-salmeron-escobar","tag-manuel-de-la-mata-garcia","tag-martin-ruiz-jose-luis"],"_links":{"self":[{"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/posts\/33920","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/comments?post=33920"}],"version-history":[{"count":0,"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/posts\/33920\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/media?parent=33920"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/categories?post=33920"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/tags?post=33920"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}